Allspring Global Investments
NVRO

Allspring Global Investments’s NEVRO CORP. NVRO Stock Holding History

Allspring Global Investments’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-46
Closed -$257 – 2477
2024
Q3 		$257 Buy
+46
New +$322 ﹤0.01% 2403
2023
Q4 		– Sell
-2,041
Closed -$39.2K – 2799
2023
Q3 		$39.2K Buy
2,041
+603
+42% +$12.9K ﹤0.01% 2340
2023
Q2 		$36.6K Sell
1,438
-1,439
-50% -$41.5K ﹤0.01% 2358
2023
Q1 		$104K Buy
2,877
+1,264
+78% +$44.4K ﹤0.01% 2036
2022
Q4 		$63.9K Sell
1,613
-36
-2% -$1.5K ﹤0.01% 2247
2022
Q3 		$76K Sell
1,649
-183
-10% -$8.49K ﹤0.01% 2189
2022
Q2 		$80K Sell
1,832
-294
-14% -$16.2K ﹤0.01% 2127
2022
Q1 		$153K Buy
2,126
+371
+21% +$26.7K ﹤0.01% 2653
2021
Q4 		$142K Buy
+1,755
New +$176K ﹤0.01% 2710

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Allspring Global Investments's NVRO Position: Q4 2024 in Review

Allspring Global Investments sold out of NEVRO CORP. (NVRO) in Q4 2024, closing a stake of 46 shares — an estimated $257 sold.

Allspring Global Investments first reported a position in NVRO in Q4 2021 and held it in 9 quarters. The position peaked at $153K in Q1 2022. 129 funds tracked by Wall St. Rank hold NVRO as of Q4 2024.

  • Allspring Global Investments reported no remaining NEVRO CORP. position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 46 NEVRO CORP. shares in Q4 2024, an estimated $257.
  • Allspring Global Investments first reported a position in NEVRO CORP. in Q4 2021 and held it in 9 quarters.
  • Allspring Global Investments's NEVRO CORP. position peaked at $153K in Q1 2022.
  • 129 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.